venlafaxine hydrochloride has been researched along with mianserin in 128 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (10.16) | 18.2507 |
| 2000's | 59 (46.09) | 29.6817 |
| 2010's | 54 (42.19) | 24.3611 |
| 2020's | 2 (1.56) | 2.80 |
| Authors | Studies |
|---|---|
| de Koning, FH; Egberts, AC; Lenderink, AW; Leufkens, HG | 1 |
| Frazer, A | 1 |
| Nelson, JC | 2 |
| Hesselink, JK; Panagides, J; Pinder, R; Sambunaris, A; Stahl, SM | 1 |
| Pinder, RM | 1 |
| Stahl, SM | 1 |
| Nemeroff, CB; Owen, JR | 1 |
| Danjou, PE; O'Hanlon, JF; Robbe, HW; van Leeuwen, C; Vermeeren, A | 1 |
| Birkenhäger, TK; Moleman, P | 1 |
| Gorman, JM | 1 |
| Thase, ME | 1 |
| Nierenberg, AA; Wright, EC | 1 |
| Kent, JM | 1 |
| Blass, DM; Pearson, VE | 1 |
| Kleinschmidt, R; Lucht, MJ; Maier, W; Rietschel, M | 1 |
| Gorman, JM; Nierenberg, AA; Stahl, SM | 1 |
| Blier, P | 2 |
| Nierenberg, AA | 1 |
| Ansseau, M; Guelfi, JD; Kørsgaard, S; Timmerman, L | 1 |
| Cohen, NL; Kennedy, SH; Lam, RW; Wan, DD | 1 |
| Anghelescu, I; Dahmen, N; Klawe, C | 1 |
| Benkert, O; Muller, M; Szegedi, A | 1 |
| Bobkiewicz-Kozłowska, T; Kus, K; Nowakowska, E | 1 |
| Dimellis, D | 1 |
| Haack, M; Hinze-Selch, D; Koethe, D; Kraus, T; Pollmächer, T; Schuld, A | 1 |
| Gupta, S; Masand, PS | 1 |
| Burrows, GD; Gupta, RK; Tiller, JW | 1 |
| Grauer, MT; Holsboer, F; Uhr, M | 1 |
| Roxanas, MG | 1 |
| Houlihan, DJ | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Bateman, DN; Dhaun, N; Good, AM; Kelly, CA; Laing, WJ; Strachan, FE | 1 |
| Norman, TR; Olver, JS | 1 |
| Alamo, C; López-Muñoz, F; Rubio, G; San, L | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Unsal, M; Yaris, E; Yaris, F | 1 |
| Mitchell, PB | 1 |
| Liappas, J; Paparrigopoulos, T; Rabavilas, A; Tzavellas, E | 1 |
| Carey, TS; Gartlehner, G; Gaynes, BN; Hansen, RA; Lohr, KN; Randolph, LC | 1 |
| Alevizos, B; Alevizos, E; Vaidakis, N | 1 |
| Biggio, G; Cherchi, G; Dazzi, L; Seu, E | 1 |
| Almási, J; Rihmer, Z | 1 |
| Benazzi, F | 1 |
| Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
| Cavanagh, J; Dempsey, MF; Dewar, D; Eersels, J; Patterson, J; Pimlott, S; Wyper, D | 1 |
| Baker, RA; Benkert, O; Heinrich, C; Heukels, A; Kohnen, R; Philipp, M; Schutte, AJ; Simmons, JH; Szegedi, A; van der Vegte-Senden, M | 1 |
| Al-Adwani, A | 1 |
| Lakatos, L; Rihmer, Z | 1 |
| Albertazzi, P | 1 |
| Amann, B; Hegerl, U; Juckel, G; Mergl, R; Mulert, C; Padberg, F; Pogarell, O; Sterr, A | 1 |
| Valenstein, M | 1 |
| Biggs, MM; Davis, L; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Akinpeloye, HO; Hamzah, Z; Hannan, N; Meagher, D | 1 |
| Ghaemi, SN; Wingo, AP | 1 |
| Connor, K; Davidson, JR; Vaishnavi, S | 1 |
| Dubarek, W; Kucia, K | 1 |
| Fava, M; Papakostas, GI; Thase, ME | 1 |
| Källén, B; Lennestål, R | 1 |
| Berk, M; Malhi, GS; Ng, F | 1 |
| Han, C; Joe, SH; Jung, IK; Ko, YH; Lee, BH; Masand, PS; Pae, CU; Patkar, AA | 1 |
| Gourion, D | 1 |
| Kálmán, J | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Schilling, C; Weber-Hamann, B | 1 |
| Cunha, FT; Ladeira, RB; Nicolato, R; Salgado, JV; Teixeira, AL | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Jung, YE; Seo, HJ; Woo, YS | 1 |
| Hassan, M; Marcus, SC; Olfson, M | 1 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| Arellano, J; Baird, J; Benedict, A; De Cock, E | 1 |
| Chung, SK; Hong, JP; Kang, EH; Kim, EJ; Kim, S; Lee, IS; Lee, SY; Oh, KS; Park, JE; Woo, JM; Yu, BH | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Hamann, B; Kopf, D; Lederbogen, F; Lewicka, S; Onken, V; Römer, B; Schilling, C | 1 |
| Arnheim, K | 1 |
| Grønli, O; Olstad, R; Stensland, GØ; Wynn, R | 1 |
| Bergeron, R; Blier, P; Hébert, C; Laberge, L; Tremblay, P; Ward, HE | 1 |
| Deuschle, M; Gilles, M; Hamann-Weber, B; Kopf, D; Lederbogen, F; Luppa, P; Paslakis, G | 1 |
| Angermeier, T; Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Schilling, C; Weber-Hamann, B; Westphal, S | 1 |
| Bach, A; Deuschle, M; Feuerhack, A; Frankhauser, P; Gilles, M; Hamann, B; Kopf, D; Lederbogen, F; Onken, V; Scharnholz, B; Schilling, C | 1 |
| Rush, AJ | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Scharnholz, B; Schilling, C; Weber-Hamann, B | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 3 |
| Cao, L; Chen, J; Cui, X; Fang, Y; Gao, K; Hong, W; Jiang, K; Nierenberg, AA; Wang, Y; Wu, Z; Xu, Y; Yi, Z; Yuan, C | 1 |
| Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
| Arias, LH; Carvajal, A; del Pozo, JG; Lobato, CT; Ortega, S; Velasco, A | 1 |
| Bokde, AL; Brückmann, H; Frodl, T; Hampel, H; Koutsouleris, N; Linn, J; Meisenzahl, E; Möller, HJ; Scheuerecker, J; Schoepf, V; Wiesmann, M | 1 |
| Rueda-Villar, T; Ruiz-Doblado, S; Sanz-Cortes, S; Zurita-Gotor, P | 1 |
| Hasselstrøm, J | 1 |
| Bateman, DN; Graham, A; Gray, J; Howell, C; Waring, WS; Wilson, AD | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Chaney, A; Frodl, T; Lisiecka, D; Meisenzahl, E; Moeller, HJ; Scheuerecker, J; Schoepf, V; Whitty, P; Wiesmann, M | 1 |
| Angermeier, T; Deuschle, M; Gilles, M; Hummel, J; Kopf, D; Lederbogen, F; Luley, C; Weber-Hamann, B; Westphal, S | 1 |
| Bahk, WM; Jun, TY; Jung, YE; Kim, KS | 1 |
| Davis, LL; Fava, M; Friedman, ES; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Kostek, H; Kujawa, A; Majewska, M; Pyra, E; Szponar, J | 1 |
| Fava, M; Kallenberg, G; Lebowitz, B; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Nakagawa, A; Omori, IM; Watanabe, N | 1 |
| Lee, KU; Lee, YM | 1 |
| Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Al-Najjar, T; Ali, BA; Nazer, LH; Shankar, G | 1 |
| Fava, M; Haley, CL; Kurian, BT; Morris, DW; Nierenberg, AA; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| De Winter, S; Decoutere, L; Fagard, K; Schrooten, M; Spriet, I; Tournoy, J; Vander Weyden, L | 1 |
| Deuschle, M; Gilles, M; Gronau, W; Kopf, D; Lecei, O; Lederbogen, F; Roth, HJ; Scharnholz, B; Schilling, C; Terhardt, J; Weber-Hamann, B | 1 |
| Deuschle, M; Gilles, M; Hellweg, R; Lang, UE; Lederbogen, F; Scharnholz, B | 1 |
| Balasubramani, GK; Kurian, B; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S | 1 |
| Blum, WF; Colla, M; Daseking, E; Deuschle, M; Gilles, M; Heuser, I; Kopf, D; Krumm, B; Lederbogen, F; Schilling, C; Weber-Hamann, B; Wudy, SA | 1 |
| Bech, BH; Christensen, J; Kjaersgaard, MI; Olsen, J; Parner, ET; Pedersen, LH; Sørensen, MJ; Vestergaard, M | 1 |
| Bognár, Z; Gazdag, G; Vonyik, G | 1 |
| Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S | 1 |
| Deuschle, M; Gilles, M; Hamann, B; Lederbogen, F; Paslakis, G; Westphal, S | 1 |
| Deuschle, M; Gilles, M; Gronau, W; Lederbogen, F; Paslakis, G; Schilling, C; Weber-Hamann, B | 1 |
| Luther, JF; Rush, AJ; Sung, SC; Trivedi, MH; Wisniewski, SR | 1 |
| Ehler, E; Meleková, A | 1 |
| Deuschle, M; Gilles, M; Kahl, KG; Scharnholz, B | 1 |
| Messer, T | 1 |
| Alessi-Severini, S; Bolton, J; Chateau, D; Enns, MW; Leong, C; Prior, HJ; Sareen, J | 1 |
| Chang, LR; Chen, IM; Chen, TT; Huang, WL; Kuo, TB; Liao, SC; Yang, CC | 1 |
| Arbus, C; Schmitt, L; Yrondi, A | 1 |
| Andersen, SE; Gislasson, G; Hansen, AH; Holm, EA; Leth-Møller, KB; Torp-Pedersen, C; Torstensson, M; Ødum, L | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Li, Y; Lu, X; Tao, C; Yan, W | 1 |
| Chekroud, AM; Gueorguieva, R; Krumholz, HM; Krystal, JH; McCarthy, G; Trivedi, MH | 1 |
| Gadad, BS; Greer, TL; Jha, MK; Mayes, TL; Minhajuddin, A; Trivedi, MH | 1 |
| Fay, B; Gründer, G; Haen, E; Hiemke, C; Paulzen, M; Schoretsanitis, G; Unholzer, S | 1 |
| Dronamraju, N; Greer, TL; Jha, MK; Minhajuddin, A; Trivedi, MH; Wakhlu, S | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Oda, Y; Sato, A; Shimizu, T; Shimoda, K; Shinozaki, M; Suzuki, Y; Yang, M; Yasui-Furukori, N | 1 |
| Keidan, L; Pick, CG; Schreiber, S | 1 |
31 review(s) available for venlafaxine hydrochloride and mianserin
| Article | Year |
|---|---|
Antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1997 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride | 1997 |
Development of new antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Approval; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Receptors, Adrenergic; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Dopamine; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Triazoles; Venlafaxine Hydrochloride | 1998 |
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Humans; Isoenzymes; Mianserin; Mirtazapine; Piperazines; Risk Factors; Triazoles; Venlafaxine Hydrochloride | 1998 |
[Two new antidepressants: mirtazapine and venlafaxine].
Topics: Adrenergic alpha-Antagonists; Benzamides; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Monoamine Oxidase Inhibitors; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 1999 |
Mirtazapine: clinical overview.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Meta-Analysis as Topic; Mianserin; Middle Aged; Mirtazapine; Placebos; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Antidepressant treatment of the depressed patient with insomnia.
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1999 |
Evolution of remission as the new standard in the treatment of depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Prevalence; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Morpholines; Piperazines; Reboxetine; Structure-Activity Relationship; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2000 |
Evidence of early onset of antidepressant effect in randomized controlled trials.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Mianserin; Mirtazapine; Personality Inventory; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Pharmacology of rapid-onset antidepressant treatment strategies.
Topics: Antidepressive Agents, Tricyclic; Autoreceptors; Cyclohexanols; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Hippocampus; Humans; Mianserin; Mirtazapine; Norepinephrine; Pindolol; Pyramidal Cells; Raphe Nuclei; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Do some antidepressants work faster than others?
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Combining antidepressants for treatment-resistant depression: a review.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mianserin; Monoamine Oxidase Inhibitors; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
An overview of the clinical efficacy of mirtazapine.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
[Pharmacological justification for the use of new antidepressant drugs].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Triazoles; Venlafaxine Hydrochloride | 2002 |
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Drug Interactions; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Triazoles; Venlafaxine Hydrochloride; Weight Gain | 2002 |
Dual action antidepressants and some important considerations.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Second-Generation; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Histamine H1 Antagonists; Humans; Mianserin; Milnacipran; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Venlafaxine Hydrochloride; Weight Gain | 2003 |
New formulations of existing antidepressants: advantages in the management of depression.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Evaluation; Fluoxetine; Humans; Mianserin; Mirtazapine; Molecular Conformation; Venlafaxine Hydrochloride | 2004 |
Therapeutic drug monitoring of non-tricyclic antidepressant drugs.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Monitoring; Humans; Mianserin; Piperazines; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Outpatients; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Refusal; Venlafaxine Hydrochloride | 2005 |
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
[1+1 or 2x1? Another form of dual antidepressive mechanism of action].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Cyclohexanols; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2005 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
[Applications and safety of modern antidepressants in patients with liver diseases].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 2007 |
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
Topics: Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
Topics: Affect; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Mianserin; Mirtazapine; Patient Satisfaction; Personality Inventory; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Suicide Prevention; Thiophenes; Time Factors; Treatment Refusal; Venlafaxine Hydrochloride | 2008 |
[Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antidepressive Agents; Apolipoprotein E4; Benzodiazepines; Citalopram; Cyclohexanols; Disease Models, Animal; Gene Expression Regulation; Humans; Hungary; Mianserin; Mirtazapine; Oxidative Stress; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Mirtazapine versus other antidepressive agents for depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2011 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
32 trial(s) available for venlafaxine hydrochloride and mianserin
| Article | Year |
|---|---|
Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Automobile Driving; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Mianserin; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2001 |
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Body Weight; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Leptin; Longitudinal Studies; Male; Mianserin; Middle Aged; Mirtazapine; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2002 |
Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Personality Inventory; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Central Nervous System Depressants; Cyclohexanols; Depressive Disorder; Ethanol; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Socioeconomic Factors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2005 |
Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Psychiatric Status Rating Scales; Tablets; Time Factors; Venlafaxine Hydrochloride | 2006 |
Keeping our eyes on STAR*D.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride | 2006 |
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Interviews as Topic; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Patient Dropouts; Prospective Studies; Somatoform Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia; Yawning | 2008 |
Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 2009 |
Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Somatosensory Disorders; Venlafaxine Hydrochloride | 2009 |
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Topics: Adult; Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychometrics; Secondary Prevention; Venlafaxine Hydrochloride | 2010 |
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Antidepressive Agents; Case-Control Studies; Cyclohexanols; Dehydroepiandrosterone Sulfate; Depression; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Saliva; Secondary Prevention; Sex Factors; Venlafaxine Hydrochloride | 2010 |
Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Retinol-Binding Proteins, Plasma; Venlafaxine Hydrochloride | 2010 |
Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Circadian Rhythm; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Saliva; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; China; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Basal Ganglia; Brain; Cyclohexanols; Depressive Disorder, Major; Emotions; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Prefrontal Cortex; Psychiatric Status Rating Scales; Time Factors; Venlafaxine Hydrochloride | 2011 |
Neural correlates of treatment outcome in major depression.
Topics: Adult; Affect; Antidepressive Agents; Biomarkers; Cerebral Cortex; Cyclohexanols; Depressive Disorder, Major; Face; Female; Frontal Lobe; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Net; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prospective Studies; Triglycerides; Venlafaxine Hydrochloride | 2011 |
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Regression Analysis; Risk Factors; Self Report; Single-Blind Method; Suicidal Ideation; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Norepinephrine; Venlafaxine Hydrochloride | 2012 |
Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Bupropion; Child Abuse; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Self Report; Severity of Illness Index; Single-Blind Method; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Biomarkers; Body Mass Index; Cyclohexanols; Depression; Female; Humans; Leptin; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Time Factors; Treatment Outcome; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain; Young Adult | 2013 |
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Unstimulated and glucose-stimulated ghrelin in depressed patients and controls.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Appetite Regulation; Biomarkers; Blood Glucose; Depression; Female; Ghrelin; Glucose Tolerance Test; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Platelet Count; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2015 |
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Predictive Value of Tests; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2015 |
Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Body Mass Index; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Overweight; Patient Selection; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
65 other study(ies) available for venlafaxine hydrochloride and mianserin
| Article | Year |
|---|---|
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Utilization; Humans; Mianserin; Middle Aged; Mirtazapine; Netherlands; Sertraline; Venlafaxine Hydrochloride | 1997 |
Designing a new generation of antidepressant drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Drug Design; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Rats; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 1997 |
Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
SIADH with multiple antidepressants in a geriatric patient.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Agranulocytosis during treatment with mianserin and venlafaxine.
Topics: Aged; Agranulocytosis; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Mianserin; Venlafaxine Hydrochloride | 2000 |
Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.
Topics: Agranulocytosis; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Drug Hypersensitivity; Female; Humans; Leukopenia; Mianserin; Middle Aged; Mirtazapine; Neutropenia; Venlafaxine Hydrochloride | 2002 |
Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lorazepam; Mianserin; Mirtazapine; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2002 |
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Cyclohexanols; Doxepin; Drug Resistance, Multiple; Gene Expression; Injections, Subcutaneous; Kidney; Liver; Male; Mianserin; Mice; Mice, Knockout; Mirtazapine; Paroxetine; Point Mutation; Spleen; Venlafaxine Hydrochloride | 2003 |
Mirtazapine-induced hyponatraemia.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Female; Humans; Hyponatremia; Mianserin; Mirtazapine; Venlafaxine Hydrochloride | 2003 |
Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine.
Topics: Analgesics, Opioid; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pain; Polypharmacy; Serotonin Syndrome; Tramadol; Venlafaxine Hydrochloride | 2004 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Comparative toxicity of citalopram and the newer antidepressants after overdose.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Drug Overdose; Female; Humans; Male; Mianserin; Mirtazapine; Piperazines; Poisoning; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 2004 |
Newer antidepressants in pregnancy: prospective outcome of a case series.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Piperazines; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Teratogens; Triazoles; Turkey; Venlafaxine Hydrochloride | 2004 |
Increased libido with the combined use of venlafaxine and mirtazapine.
Topics: Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Libido; Mianserin; Middle Aged; Mirtazapine; Venlafaxine Hydrochloride | 2005 |
Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.
Topics: Animals; Antidepressive Agents, Tricyclic; Cerebral Cortex; Cyclohexanols; Electroshock; Extracellular Space; Fluvoxamine; Foot; Male; Mianserin; Microdialysis; Mirtazapine; Neurons; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Venlafaxine Hydrochloride | 2005 |
Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epistaxis; Gastrointestinal Hemorrhage; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients.
Topics: Adult; Aging; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Female; Humans; Image Processing, Computer-Assisted; Male; Mianserin; Middle Aged; Mirtazapine; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon; Tropanes; Venlafaxine Hydrochloride | 2006 |
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Hemorrhage; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroencephalography; Epilepsy; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2006 |
Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Medical Audit; Mianserin; Middle Aged; Mirtazapine; Retrospective Studies; Venlafaxine Hydrochloride; Weight Gain | 2007 |
STAR*D level IV methodology.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Research Design; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Delivery outcome in relation to maternal use of some recently introduced antidepressants.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adrenergic Uptake Inhibitors; Antidepressive Agents; Birth Weight; Cyclohexanols; Databases, Factual; Delivery, Obstetric; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Mianserin; Mirtazapine; Morpholines; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Reboxetine; Registries; Selective Serotonin Reuptake Inhibitors; Smoking; Sweden; Venlafaxine Hydrochloride | 2007 |
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cyclohexanols; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Mianserin; Middle Aged; Mirtazapine; Venlafaxine Hydrochloride | 2008 |
[Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Mianserin; Mirtazapine; Venlafaxine Hydrochloride | 2008 |
Antidepressant switching among adherent patients treated for depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult | 2009 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.
Topics: Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Duloxetine Hydrochloride; Health Care Costs; Humans; Mianserin; Mirtazapine; Prevalence; Quality of Life; Recurrence; Remission Induction; Scotland; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2010 |
Cortisol metabolism in depressed patients and healthy controls.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cortisone; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Mianserin; Middle Aged; Mirtazapine; Tetrahydrocortisol; Tetrahydrocortisone; Venlafaxine Hydrochloride; Young Adult | 2009 |
[Psycho- and pharmacotherapy of depressions. So you combine correctly].
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Humans; Mianserin; Middle Aged; Mirtazapine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Neurotrophic factors in serum following ECT: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Growth Factors; Pilot Projects; Psychotherapy; Psychotropic Drugs; Recurrence; Reference Values; Venlafaxine Hydrochloride | 2009 |
Does night-time cortisol excretion normalize in the long-term course of depression?
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Circadian Rhythm; Cyclohexanols; Depressive Disorder; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Pituitary-Adrenal System; Time Factors; Venlafaxine Hydrochloride | 2010 |
Combining antidepressant medications: a good idea?
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption.
Topics: Antidepressive Agents; Cyclohexanols; Databases, Factual; Drug Costs; Humans; Lithium Compounds; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Spain; Suicide; Venlafaxine Hydrochloride | 2010 |
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2010 |
Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Severity of Illness Index; Venlafaxine Hydrochloride | 2010 |
Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.
Topics: Antidepressive Agents; Antipsychotic Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dibenzothiazepines; Humans; Methanol; Mianserin; Mirtazapine; Piperazines; Quetiapine Fumarate; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles; Venlafaxine Hydrochloride; Zinc Sulfate | 2011 |
Evaluation of a QT nomogram for risk assessment after antidepressant overdose.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Drug Overdose; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Mianserin; Mirtazapine; Nomograms; Retrospective Studies; Risk Assessment; Torsades de Pointes; Venlafaxine Hydrochloride | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hyponatremia; Male; Mianserin; Middle Aged; Mirtazapine; Republic of Korea; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sodium; Venlafaxine Hydrochloride; Young Adult | 2011 |
[Serotonin syndrome in the course of drug-poisoning--case presentation].
Topics: Alcoholic Intoxication; Alkaloids; Azocines; Bradycardia; Cyclohexanols; Depressive Disorder; Electrocardiography; Female; Humans; Mianserin; Middle Aged; Moclobemide; Myoclonus; Quinolizines; Respiratory Insufficiency; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Suicide, Attempted; Venlafaxine Hydrochloride | 2011 |
Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Korea; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Outpatients; Paroxetine; Retrospective Studies; Venlafaxine Hydrochloride | 2011 |
Fatal agranulocytosis associated with psychotropic medication use.
Topics: Adult; Agranulocytosis; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Blood Cell Count; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Fatal Outcome; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lamotrigine; Mianserin; Mirtazapine; Multiple Organ Failure; Neutropenia; Orbital Cellulitis; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Recombinant Proteins; Shock, Septic; Triazines; Venlafaxine Hydrochloride | 2012 |
A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge.
Topics: Aged, 80 and over; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Serotonin Syndrome; Venlafaxine Hydrochloride | 2012 |
Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
Topics: Abortion, Spontaneous; Adult; Antidepressive Agents; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Humans; Maternal-Fetal Exchange; Mianserin; Mirtazapine; Pregnancy; Risk; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2013 |
[Antidepressant treatment associated hyponatremia -- case report].
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Critical Care; Cyclohexanols; Depression; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hyponatremia; Male; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Sodium; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Neuromyotonia with polyneuropathy, prominent psychoorganic syndrome, insomnia, and suicidal behavior without antibodies: a case report.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Second-Generation; Electromyography; Humans; Immunoglobulins, Intravenous; Isaacs Syndrome; Male; Mianserin; Mirtazapine; Polyneuropathies; Sleep Initiation and Maintenance Disorders; Suicide, Attempted; Venlafaxine Hydrochloride | 2015 |
Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF).
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome; Vascular Endothelial Growth Factor A; Venlafaxine Hydrochloride | 2015 |
[Cognitive dysfunction in major depression].
Topics: Attention; Cognition Disorders; Depressive Disorder, Major; Drug Therapy, Combination; Executive Function; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Rehabilitation, Vocational; Stress, Psychological; Venlafaxine Hydrochloride | 2015 |
New antidepressant use in older adults: a Canadian population-based study (1997-2013).
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Sectional Studies; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Manitoba; Mianserin; Middle Aged; Mirtazapine; Retrospective Studies; Trazodone; Venlafaxine Hydrochloride | 2017 |
The Effects of Antidepressants and Quetiapine on Heart Rate Variability.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Depression; Female; Heart Rate; Humans; Linear Models; Male; Medically Unexplained Symptoms; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Sertraline; Taiwan; Venlafaxine Hydrochloride | 2016 |
["Alice in wonderland syndrome", a precursor of depressive disorder with melancholic characteristics].
Topics: Aged; Alice in Wonderland Syndrome; Antidepressive Agents, Second-Generation; Antimanic Agents; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Mianserin; Mirtazapine; Treatment Outcome; Venlafaxine Hydrochloride | 2017 |
Antidepressants and the risk of hyponatremia: a Danish register-based population study.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Denmark; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Incidence; Male; Mianserin; Middle Aged; Mirtazapine; Registries; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sodium; Venlafaxine Hydrochloride | 2016 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Bupropion; Citalopram; Cluster Analysis; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Randomized Controlled Trials as Topic; Sleep; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2017 |
Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Bupropion; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Inflammation; Interleukin-17; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Severity of Illness Index; T-Lymphocytes; Venlafaxine Hydrochloride | 2017 |
Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Databases, Factual; Desvenlafaxine Succinate; Doxepin; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polypharmacy; Venlafaxine Hydrochloride | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: Two case reports.
Topics: Aged; Aged, 80 and over; Depression; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Mianserin; Pain; Venlafaxine Hydrochloride | 2022 |
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride | 2023 |